POPULARITY
VOV1 - Xã Vũ Thư, tỉnh Hưng Yên đang thực hiện một hình thức tiếp xúc cử tri mới, đó là mô hình “Đại biểu HĐND uống trà nghe dân nói”. Không hội trường, không bục phát biểu, không trình bày báo cáo một chiều, các cuộc gặp diễn ra ngay tại khu dân cư, bên bàn trà mộc mạc. Một sáng mùa hè tại góc sân Nhà thờ Nguyệt Lãng, thôn Hồng Phong, dưới tán cây nhãn xanh mát, gần chục bộ bàn ghế được xếp ngay ngắn thành hình chữ nhật, nơi đại biểu HĐND xã Vũ Thư cùng cán bộ thôn và người dân quây quần với nhau bên chén nước chè xanh, râm ran những lời hỏi thăm ân cần.Một trong những người đến sớm nhất là ông Đặng Văn Xuyền- cựu chiến binh khuyết tật, đi xe 3 bánh đến. Chưa lần nào được tham dự các buổi tiếp xúc cử tri tại hội trường do gặp khó khăn trong đi lại, lần này ông Xuyền được gặp đại biểu dân cử ngay tại thôn quê, trong không khí thân mật, gần gũi, dễ dàng mở lời, kiến nghị những vấn đề mà gia đình ông và chòm xóm quan tâm.Khi khoảng cách được thu hẹp bằng sự gần gũi và chân tình, những người dân bình dị nhất cũng dễ dàng chia sẻ những câu chuyện thật nhất, những vấn đề nóng nhất từ thực tiễn cơ sở. Cũng tại mô hình mới này, một số vấn đề cử tri quan tâm được cán bộ xã giải quyết ngay trên bàn trà, cũng có những kiến nghị cần phải có thời gian mới thực hiện được; Nhưng khi ra về, mỗi người dân đều cảm thấy mình được tôn trọng và tin tưởng vào kế hoạch giải quyết của đảng ủy, chính quyền địa phương.Sau hơn 2 tháng thực hiện, mô hình này bước đầu cho thấy một hình thức tiếp xúc cử tri thiết thực, gần gũi, trở thành kênh đối thoại trực tiếp giữa cấp ủy, chính quyền, đại biểu dân cử với nhân dân. Vậy làm thế nào để mô hình này thực sự phát huy hiệu quả, tránh hình thức và không rơi vào tình trạng đánh trống bỏ dùi? Đây là vấn đề được bàn luận trong Chương trình Đối thoại, với sự tham gia của 2 vị khách mời: Bà Phạm Thị Như Phong, Bí thư Đảng ủy, Chủ tịch Hội đồng nhân dân xã Vũ Thư và ông Phan Hùng Sơn, Trưởng thôn Minh Quang, Đại biểu HĐND xã Vũ Thư, tỉnh Hưng Yên./.Văn Hải/VOV1Đại biểu HĐND xã Vũ Thư uống trà nghe người dân thôn Hồng Phong nói
Please visit answersincme.com/ZPW860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by David R. Staskin, MD. In this activity, an expert in urology discusses strategies to diagnose and individualize treatment for overactive bladder (OAB) in patients with benign prostatic hyperplasia (BPH), including the role of beta-3 adrenergic agonists and guideline-based care. Upon completion of this activity, participants should be better able to: Identify strategies to diagnose overactive bladder (OAB) in patients with benign prostatic hyperplasia (BPH); Assess the evidence for beta-3 adrenergic agonists in the treatment of OAB among patients with BPH; and Outline approaches to tailor OAB treatment for individual patients with BPH.
Innovations in the Surgical Management of BPH (2026) CME Available: https://cme.auanet.org/URL/surgical-treatment-bph-2026 LEARNING OBJECTIVES: After participating in this educational series, participants will be able to: 1. Utilize the newly released AUA Guidelines Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia in practice. 2. Discuss the evidence base for current technologies, including pivotal studies, and be able to define the role and clinical expectation for each of them. 3. Interpret the current clinical results and compare the patient experiences of these treatments in relation to more established and even abandoned treatments for patient groups with similar characteristics. 4. Differentiate between each of the new technologies for treating BPH/LUTS based on both their mode-of-action and the quality of their supporting evidence. ACKNOWLEDGEMENTS: Support provided by independent educational grants from: - Olympus Corporation of the Americas - Teleflex Interventional Urology © 2026 AMERICAN UROLOGICAL ASSOCIATION. ALL RIGHTS RESERVED. ATTENTION: You are prohibited from using or uploading content you accessed through this activity into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
Send Zorba a message!Zorba looks at new research that shows doing nothing for 10 minutes a day can be good for us. He walks us through his delicious summer time picnic recipe for Chicken Salad, and he helps a listener who has questions about HRT, sleep, and mixing Pepcid and Allegra. He helps out a listener who asks if there is a connection between dementia and mixing prescription drugs. And we hear a mom joke that Zorba isn't quite sure about.Support the showProduction, edit, and music by Karl ChristensonSend your question to Dr. Zorba (he loves to help!):Phone: 608-492-9292 (call anytime)Email: askdoctorzorba@gmail.comWeb: www.doctorzorba.orgStay well!
Send Zorba a message!Zorba looks at new research that shows doing nothing for 10 minutes a day can be good for us. He walks us through his delicious summer time picnic recipe for Chicken Salad, and he helps a listener who has questions about HRT, sleep, and mixing Pepcid and Allegra. He helps out a listener who asks if there is a connection between dementia and mixing prescription drugs. And we hear a mom joke that Zorba isn't quite sure about.Support the showProduction, edit, and music by Karl ChristensonSend your question to Dr. Zorba (he loves to help!):Phone: 608-492-9292 (call anytime)Email: askdoctorzorba@gmail.comWeb: www.doctorzorba.orgStay well!
In this episode of AUANews Inside Tract, host Dr. Mark Edney speaks with Dr. Helen Burnie about the FDA's proposed updates to testosterone therapy labeling and what they could mean for urologists, patients, and the broader field of men's health. The discussion explores new evidence on cardiovascular safety, prostate cancer, BPH, and appropriate patient selection, while emphasizing the importance of evidence-based prescribing, shared decision-making, fertility counseling, and ongoing monitoring.
Your nightly trips to the bathroom may be telling you much more than you realize.In this episode, discover how an enlarged prostate can affect your sleep, urinary health, and even your sex life as you get older. You'll also learn the truth about CBD, tadalafil, prostate inflammation, and the warning signs you shouldn't ignore. Early detection and the right lifestyle choices can make a meaningful difference in your long-term health.Tune in now to learn how to recognize the symptoms of BPH and protect your prostate before small problems become bigger ones.--------------Key TakeawaysBPH is a common condition that causes prostate enlargement.Frequent nighttime urination may be an early sign of BPH.A weak urine stream can result from an enlarged prostate.Incomplete bladder emptying is a common BPH symptom.BPH can indirectly affect your sex life and erectile function.Tadalafil is commonly prescribed to help manage BPH symptoms.CBD may be taken with tadalafil, but some products contain THC.A Mediterranean diet may help reduce prostate inflammation.Limiting alcohol may support better prostate health.Regular prostate exams and PSA screenings are important after age 45 or earlier if you're at higher risk.--------------Resources mentioned:Modern Man CribMediterranean DietGood Morning Wood SmoothieRenew with Dr. Anne--------------Curious about how you can boost your bedroom game and build lasting confidence? Check out the course at getwoodnow.com and start your journey to feeling like yourself again!--------------If you enjoyed this episode and want to learn more and get more tips, subscribe to The Modern Man newsletter for exclusive content delivered straight to your inbox! https://dranne.co/themodernman--------------Follow Me On:InstagramTwitterFacebookTikTokYouTube--------------For all links and resources mentioned on the show and where to subscribe to the podcast, please visit https://truongrehab.com/enlarged-prostate-nighttime-urination-treatment--------------Want to regain control of your sex life? It's time to reverse the effects of ED on your life. Join the Modern Man Club and embark on your journey to complete recovery and community.--------------Reveal the FREE treatment most men ignore that solves thousands of erectile dysfunction cases every year, plus the 5 biggest mistakes you must avoid if you want to say goodbye to your ED. Uncover it all in my free eBook, available to download now.https://dranne.co/ebook
** PLEASE PARDON THE TECHNICAL DIFFICULTIES IN THE LAST TWO MINUTES OF THIS EPISODE **In this episode of The Armor Men's Health Show, Donna Lee is joined once again by Dustin Fontenot, PA-C, of Urology Specialists of Austin, the practice behind this entertaining and educational podcast dedicated to men's health.Each month, Donna and Dustin tackle some of the most misunderstood, taboo, and often embarrassing topics in urology—because if men are hesitant to ask the questions, someone needs to answer them!This week, they dive into the fascinating and rare condition known as Post-Orgasmic Illness Syndrome (POIS). While uncommon, POIS can be life-altering for those who suffer from it. Imagine experiencing severe flu-like symptoms, brain fog, fatigue, muscle aches, and intense pain after every orgasm—sometimes lasting anywhere from two to seven days. For some patients, the discomfort can reach an 8 out of 10 on the pain scale and occurs every single time.Researchers believe that many cases may be linked to an allergic or autoimmune reaction to a patient's own semen. In fact, one of the diagnostic tools used by specialists may involve allergy testing with the patient's own semen—a process that is as unusual as it sounds.Dustin explains the symptoms, possible causes, and current treatment options available to help patients manage this challenging condition. While there is no universally effective cure, some therapies may include antihistamines, allergy medications, anti-inflammatory pain relievers, and certain medications used to treat BPH that may reduce symptoms by causing retrograde ejaculation. As always, treatment plans should be discussed with a qualified urologist.Join Donna and Dustin for this eye-opening conversation about a condition most people have never heard of—but one that can dramatically impact quality of life. Be sure to subscribe to The Armor Men's Health Show for new episodes every week, and share the podcast with friends and family who enjoy learning about health topics that nobody else is talking about!
VOV1 - Sáng nay (5/6), Ban Chỉ đạo về tìm kiếm, quy tập và xác định danh tính hài cốt liệt sĩ tỉnh Quảng Ngãi tổ chức Lễ dâng hoa, dâng hương và tiến hành công tác khai quật, tìm kiếm, quy tập hài cốt liệt sĩ tại khu vực đường Trường Chinh, thuộc địa bàn phường Đắk Cấm và phường Kon Tum.Cùng ngày, tỉnh Quảng Ngãi tổ chức Lễ viếng, truy điệu và an táng 16 hài cốt liệt sĩ quân tình nguyện và chuyên gia Việt Nam hy sinh tại Lào và Campuchia được quy tập, hồi hương trong mùa khô 2025 - 2026. Bà Phạm Thị Thanh Trà, Bí thư Trung ương Đảng, Phó Thủ tướng Chính phủ, Trưởng Ban Chỉ đạo Quốc gia về tìm kiếm, quy tập và xác định danh tính hài cốt liệt sĩ tham dự các hoạt động này. Lễ dâng hoa, dâng hương được tổ chức tại Nghĩa trang Liệt sĩ Kon Tum, phường Đắk Cấm tưởng nhớ, tri ân các Anh hùng liệt sĩ đã anh dũng hy sinh vì sự nghiệp đấu tranh giải phóng dân tộc, bảo vệ Tổ quốc. Tham dự buổi lễ có lãnh đạo Ban Chỉ đạo quốc gia về tìm kiếm, quy tập và xác định danh tính hài cốt liệt sĩ; đại diện Bộ Quốc phòng, Quân khu 5, các bộ, ngành Trung ương; lãnh đạo tỉnh Quảng Ngãi cùng các nhân chứng lịch sử, cựu chiến binh và thân nhân liệt sĩ.Dâng hoa, dâng hương tại Nghĩa trang liệt sĩ Kon Tum, phường Đắk Cấm.
Longer lives bring new changes and with the right strategy, those changes don't have to limit how you feel or function.In this episode, Dr. Stephen Petteruti explains benign prostatic hypertrophy (BPH) with clarity and perspective. An enlarged prostate is often a normal part of aging, not a signal of cancer or immediate danger. The real question is how much does it affect daily life, and what can be done to manage it intelligently? He focuses on what actually moves the needle. Inflammation, body fat, and metabolic health play a central role in prostate growth and urinary symptoms, not testosterone levels. He breaks down practical steps like reduce excess body fat, managing inflammatory triggers, supporting the body with targeted antioxidants, and giving any intervention enough time to work.Rethink what's “normal,” and take one step today that improves how you live tomorrow. Watch the full episode of BPH Explained: Best Treatments for Enlarged Prostate and Frequent Urination in Men.Enjoy the podcast? Subscribe and leave a 5-star review on your favorite platforms.Dr. Stephen Petteruti is a board-certified physician specializing in longevity-focused, integrative medicine. He works with men navigating prostate cancer, testosterone and hormone health, aging, and performance using proactive, evidence-informed strategies grounded in real clinical practice. His approach prioritizes preserving function, strength, and quality of life while helping patients make clear, informed decisions beyond reactive, fear-driven care.Learn more: https://www.drstephenpetteruti.com/ Learn more: https://www.intellectualmedicine.com/ Connect with Dr. Petteruti on:Instagram: https://www.instagram.com/dr.stephenpetteruti/ Facebook: https://www.facebook.com/dr.stephenpetteruti Subscribe to Intellectual Medicine on:Apple Podcast: https://tinyurl.com/DrPetterutiApplePodcast Spotify: https://tinyurl.com/DrPetterutiSpotifyPodcast Disclaimer:The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.Produced by https://www.BroadcastYourAuthority.com
In this episode of the Clinical Update podcast, MIMS Learning deputy editor Rhiannon and medical editor Dawn provide a comprehensive update on prostate health. High-profile figures, such as Sir Chris Hoy, opening up about their own diagnoses have significantly increased public awareness of prostate cancer. In light of this, the editors discuss the rationale for targeted prostate cancer screening and patient counselling around prostate-specific antigen (PSA) tests. The conversation also highlights health inequalities in prostate cancer diagnosis, noting that Black men have double the risk of prostate cancer compared with other groups, and highlighting care for trans women, who may remain at risk of prostate cancer after gender-confirming surgery.Beyond malignancy, this episode covers the symptoms and management of benign prostatic hyperplasia (BPH) and chronic prostatitis in primary care.Educational objectivesAfter listening to this podcast, healthcare professionals should be better able to:Recall draft recommendations for targeted prostate cancer screening in high-risk groupsIdentify key risk factors for prostate cancer, including ethnicity and ageOutline factors that can raise or suppress PSA levelsUnderstand the diagnostic pathway and the role of digital rectal examinationRecognise symptoms and potential complications of BPH and prostatitisYou can access the website version of this podcast, along with a list of key learning points, on MIMS Learning - and make notes for your appraisal. MIMS Learning offers hundreds of hours of CPD for healthcare professionals, along with a handy CPD organiser.Please note: this podcast is presented by medical editors and discusses educational content written or presented by doctors, nurses and other healthcare professionals on the MIMS Learning website and at live events.This episode was produced by Jude Owen.MIMS LearningRegister for a FREE accountExpert perspective: prostate cancer diagnosisGuidance update: NICE guidelines on prostate cancerLatest updates in prostate cancer for primary careBenign prostatic hyperplasia: clinical reviewProstate Cancer UK Hosted on Acast. See acast.com/privacy for more information.
VOV1 - Ngày 14/4, Sở An toàn thực phẩm TP.HCM tổ chức lễ ký cam kết bảo đảm an toàn thực phẩm đối với các cơ sở cung cấp suất ăn và thực phẩm cho trường học trên địa bàn. Sự kiện diễn ra trong bối cảnh dư luận đặc biệt lo ngại sau hàng loạt vụ việc liên quan đến an toàn thực phẩm học đường.Theo Sở An toàn thực phẩm TP.HCM, hiện thành phố có 317 đơn vị cung ứng suất ăn bán trú cho các trường. Tại buổi lễ, đại diện 100 doanh nghiệp đã ký cam kết, đại diện cho toàn bộ các đơn vị cung ứng, nhằm nâng cao trách nhiệm và kiểm soát chất lượng bữa ăn cho học sinh.Bà Phạm Khánh Phong Lan, Giám đốc Sở An toàn thực phẩm TP.HCM cho biết, dù các đơn vị cung cấp suất ăn đều phải được thẩm định đủ điều kiện trước khi hoạt động, nhưng thực tế kiểm tra vẫn ghi nhận một số nơi chưa tuân thủ đầy đủ quy định. Các sự cố gần đây cho thấy yêu cầu cấp thiết phải siết chặt quản lý và tăng cường giám sát.Ba Phạm Khánh Phong Lan - Giám đốc Sở An toàn thực phẩm TP.HCM (Ảnh: Kim Dung)
What if your prostate symptoms aren't actually being treated—just managed?In this episode, Dr. Geo sits down with Dr. Brian Helfand, Clinical Professor at the University of Chicago and a leading expert in prostate care, to break down aqua ablation, a water-powered, precision therapy that's changing how we treat BPH (benign prostate enlargement)—and potentially even prostate cancer.What You'll Learn1. Why Medications May Not Be the Best First StepMost prostate medications manage symptoms—but don't fix the problemLong-term use may come with side effects and limited improvementMany men stay on meds for years without real resolution2. The Shift Toward Personalized Prostate CareNot all urinary symptoms come from the prostateKey contributors include:DiabetesSleep apneaAnxietyTreating the whole patient, not just the prostate, leads to better outcomes3. What is Aqua Ablation?A minimally invasive procedure that uses a high-pressure water jet to remove excess prostate tissue.Key Features:Robotically controlled for precisionGuided by real-time ultrasound imagingNo heat (unlike lasers or steam)Customized treatment plan for each patient4. Why Aqua Ablation is a Game ChangerCompared to traditional procedures:✅ Lower risk of sexual side effects✅ Minimal risk of incontinence✅ Faster recovery✅ Highly durable resultsResults:Significant improvement in urinary symptoms (~15-point IPSS improvement)Very low retreatment rate (~0.4% per year)5. The “Money Shot” Conversation (Yes, It Matters)Preservation of ejaculation is a top priority for many menAqua ablation preserves it in 90%+ of casesMany other procedures result in permanent dry orgasm6. Who is a Candidate for Treatment?There is no single number or test.Dr. Helfand looks at the full picture (“gestalt”):Symptom severity (IPSS)Patient bother levelUrinary flow strengthPost-void residual (PVR)Overall health
Benign Prostatic Hyperplasia and Prostate Cancer explained looking at the key differences in each including symptoms, diagnosis and treatment options. Includes Benign Prostatic Hyperplasia pathophysiology as well as epidemiology of both Benign Prostatic Hyperplasia and Prostate cancer. PDFs available here: https://rhesusmedicine.com/pages/urologyConsider subscribing (if you found any of the info useful!): https://www.youtube.com/channel/UCRks8wB6vgz0E7buP0L_5RQ?sub_confirmation=1Patreon: https://www.patreon.com/rhesusmedicineBuy Us A Coffee!: https://www.buymeacoffee.com/rhesusmedicineTimestamps:0:00 What are Benign Prostatic Hyperplasia and Prostate Cancer? 0:44 Normal Prostate Anatomy1:51 Benign Prostatic Hyperplasia Pathophysiology2:46 Benign Prostatic Hyperplasia vs Prostate Cancer Symptoms4:10 Benign Prostatic Hyperplasia vs Prostate Cancer Epidemiology 5:09 Benign Prostatic Hyperplasia vs Prostate Cancer Diagnosis8:17 Benign Prostatic Hyperplasia Treatment10:10 Prostate Cancer TreatmentLINK TO MNEMONICS:https://www.youtube.com/watch?v=p-XE7PiwGgE&list=PLGNSE_HvIV4t7a33bbHN1fq-j_tge0GmpLINK TO SOCIAL MEDIA: https://www.instagram.com/rhesusmedicine/ReferencesBMJ Best Practice (2026) Benign prostatic hyperplasia. Available at: https://bestpractice.bmj.com/topics/en-gb/208BMJ Best Practice (2026) Prostate cancer. Available at: https://bestpractice.bmj.com/topics/en-gb/254MSD Manual (2021) Benign prostatic hyperplasia (BPH). Available at: https://www.msdmanuals.com/professional/genitourinary-disorders/benign-prostate-disease/benign-prostatic-hyperplasiaMSD Manual (2025) Prostate cancer. Available at: https://www.msdmanuals.com/professional/oncology/genitourinary-cancers/prostate-cancerProstate Laser Center (2023) Prostate zones: what you should know. Prostate Laser Center. Available at: https://www.prostatelasercenter.com/blog/prostate-zones-what-you-should-know/Prostate Cancer UK (2025) PSA blood test. Prostate Cancer UK. Available at: https://prostatecanceruk.org/prostate-information-and-support/prostate-tests/psa-blood-testPlease remember this podcast and all content from Rhesus Medicine is meant for educational purposes only and should not be used as a guide to diagnose or to treat. Please consult a healthcare professional for medical advice. #medicalmnemonic #medicalmnemonics #rhesusmedicine #studymedicine #studygram #medstudent #medicalschool
Is your prostate running your life? If you're tired of the "trickle," the midnight bathroom runs, and pills that don't seem to work, it's time to talk about Aquablation.In this episode, Dr. Geo sits down with Dr. Brian Helfand, a world-renowned urologist and genetics expert, to discuss a breakthrough in Benign Prostatic Hyperplasia (BPH) treatment. Unlike traditional surgeries that can leave you with "dry orgasms" or permanent side effects, Aquablation uses a robotic-controlled, high-pressure cold water jet to clear the path—without the heat, without the scalpels, and with a primary focus on preserving sexual function.
Ingenion Medical, run by our guest Ed Cappabianca, is going to change the standard catheter in the UK - The Foley catheter. Urinary catheter-associated infections kill 2,100 people a year and block 1.2 million hospital bed-days. And yet, the Foley catheter - the standard of care - has barely changed in 91 years. Ingenion Medical has built what replaces it.The cymactive™ 2.0R is a CE-marked, patient-controlled urethral catheter with a patented magnetic valve that is already in clinical use across the UK and 15 international markets. It is superior to either standard Foleys or intermittent catheters, and generates revenue today. Ingenion Medical are seeking investors. Here's the Investment case:• Revenue generative, regulatory approved. CE Mark achieved Q1 2024. ISO 13485 renewed October 2025. FDA pre-sub meeting completed.• Commercial traction. Distributor agreements in over 10 countries. NHS Supply Chain at contract award stage. 15 NHS hospitals active or in pipeline.• Profitable at 1,600 patients per month (80 urologists x 20 patients). Breakeven H2 2027. £49m revenue projected 2030.• Exit precedent. Comparable urology acquisitions: Urotronic > Laborie $600m;Neotract > Teleflex $1.1b; Augmenix > Boston Scientific $600m; .• World-class advisors. Advisory board includes: Professor Chris Chapple (former European Association of Urology Secretary General) and Professor Kurt Naber, global authority on urinary tract infections.If you would like the detailed Investor Pitch Deck, go to: ingenion.approvedinvestors.co.ukSummary of PodcastKey TakeawaysThe Problem: Current catheters cause frequent, costly infections (£2k–£3.5k per cycle for the NHS) and severely limit patient mobility and quality of life.The Solution: Ingenion's cymactive catheter is a 30-day, self-voiding device with no external bag, restoring patient dignity and designed to reduce infection risk.Market Validation: The NHS created a new framework channel specifically for SimActive, signaling strong support for its innovation and cost-saving potential.The Ask: Ingenion is raising £2M (for ~10% equity) to fund commercialisation, targeting a future trade sale to a major urology firm for a potential 10x investor return.The Problem with Current CathetersUrinary Retention: A common condition caused by issues like BPH (enlarged prostate), Parkinson's, MS, and spinal cord injuries.Foley Catheter (Indwelling):The 100-year-old standard, anchored by an internal balloon.Creates a "superhighway for bacteria," causing frequent, costly infections.Full cost of ownership for the NHS is ~£800/month per patient.Intermittent Catheters (Single-Use):Used 5–8 times daily, creating significant waste and inconvenience.Account for 90% (£157.5M) of the NHS's £175M annual catheter spend.Patient Impact:Fear of infection and public voiding → social isolation.Reduced fluid intake → dehydration, which can worsen conditions like dementia.The cymactive SolutionInnovation: A 30-day, self-voiding catheter with no external tubes or bags.Mechanism:An internal, patient-controlled magnetic valve.An external magnet opens the valve; removing it allows the valve to close naturally.Infection Defense:The urethra seals over the valve's end, mimicking the body's natural defense against bacteria.Anecdotal evidence suggests reduced infections and restored function.Product Pipeline:Current: cymactive for male urinary retention (CE marked).In Development: Versions for women and for male incontinence.Market Validation & CommercialisationNHS Adoption:The NHS created a new framework channel for cymactive, as it didn't fit existing categories.Ingenion was the sole applicant and signed a 2-year contract on March 12, 2026.Ordering codes are now live for hospitals.Go-to-Market Strategy:Goal: Build awareness among clinicians and patient groups.Method: Target early adopters and use their case studies, shared by the NHS innovation team, to drive broader adoption.Rationale: A randomised control trial was unfeasible because Foley catheter users were unwilling to risk being randomised to the control group.Investment OpportunityThe Ask: £2M for ~10% equity (pre-money valuation: £18M).Exit Strategy: Trade sale to a major urology firm (e.g., Coloplast, Becton Dickinson).Rationale: Leverage a large firm's infrastructure for rapid, global scaling.Target Return: A typical venture capital return of ~10x investment.Investor Profile: High Net Worth (HNW) or Sophisticated Investors.Due Diligence: Pitch deck available at ingenion.approvedinvestors.co.ukThe Next 100 Days Podcast Co-HostsGraham ArrowsmithGraham founded Finely Fettled in 2014 to provide data from The UK High Net Worth Database to marketers targeting affluent and high-net-worth customers. He's the founder of MicroYES, a Partner for MeclabsAI, creating lead generation AI Agents & Workflows and introducing the MeclabsAI Platform. Graham also provides an Answer Engine Optimisation solution to get your website in shape to be found by LLMs.Kevin ApplebyKevin specialises in finance transformation and implementing business change. He's the COO of GrowCFO, which provides both community and CPD-accredited training designed to grow the next generation of finance leaders. You can find Kevin on LinkedIn and at kevinappleby.com
For many men, needing to urinate more often, experiencing a weak stream, or accidental leaking may seem like a natural part of aging. But actually, those changes may be an indicator of a very common and treatable condition. On this episode of the Healthier You podcast, Dr. Ashlee Williams speaks with Dr. Kai Li, a board-certified urologist with Kaiser Permanente, about enlarged prostates, also called benign prostatic hyperplasia, or BPH. We'll talk about what causes it, how to manage it, and what new treatments are offering relief without surgery. Learn more about Kai Li, MD
VOV1 - Việt Nam sẽ lần đầu tiên đăng cai tổ chức Miss World lần thứ 73 vào cuối năm nay. Bà Phạm Kim Dung – Giám đốc điều hành Công ty Sen Vàng - đơn vị đăng cai tổ chức kiện tầm cỡ quốc tế này chia sẻ.Thông tin Việt Nam sẽ lần đầu tiên đăng cai tổ chức Miss World lần thứ 73 vào cuối năm nay đang thu hút sự chú ý đặc biệt của dư luận với nhiều câu hỏi: Phải chăng, đây không chỉ là một sự kiện văn hóa – giải trí quy mô toàn cầu, mà còn là phép thử lớn về năng lực tổ chức, quảng bá hình ảnh quốc gia trong bối cảnh hội nhập sâu rộng?Hành trình để đưa một đấu trường nhan sắc danh giá bậc nhất thế giới đến Việt Nam diễn ra như thế nào? Đơn vị đăng cai là công ty Sen Vàng đã và đang có sự chuẩn bị ra sao? Phải làm gì để biến cơ hội này thành một “cú hích” cho du lịch, văn hóa và vị thế quốc gia? Bà Phạm Kim Dung – Giám đốc điều hành Công ty Sen Vàng - đơn vị đăng cai tổ chức kiện
VOV1 - Từ ngày 1/4 tới đây, chính phủ Singapore sẽ điều chỉnh tăng thời gian nghỉ phép chăm con sơ sinh, dùng chung cho cha mẹ, từ 6 tuần lên 10 tuần. Cùng với các chính sách khác, các bậc cha mẹ tại Singapore có thể được hưởng tới 30 tuần nghỉ phép để chăm sóc trẻ trong năm đầu đời.Bộ Phát triển Xã hội và Gia đình Singapore (MSF) mới đây thông báo chính sách này sẽ áp dụng đối với các cặp vợ chồng có con sinh từ ngày 1/4 trở đi, đồng thời mặc định được phân bổ đều cho cả hai người. Trong thời gian sử dụng nghỉ phép, lương và các chế độ liên quan vẫn được đảm bảo. Thời gian sử dụng nghỉ phép phải trong vòng 12 tháng kể từ ngày trẻ chào đời và chỉ được áp dụng sau khi đã sử dụng hết chế độ nghỉ thai sản và nghỉ làm cha theo quy định.Bộ này khuyến nghị các cặp vợ chồng nên thỏa thuận phương án phân bổ thời gian nghỉ dựa trên nhu cầu chăm sóc con nhỏ, đồng thời thông báo sớm cho người sử dụng lao động để thuận tiện cho việc bố trí công việc và nhân sự thay thế.Trong trường hợp không lựa chọn nghỉ luân phiên, cả hai người cũng có thể sử dụng toàn bộ thời gian nghỉ phép dùng trong một đợt liên tục, với điều kiện sử dụng trong 26 tuần đầu khi trẻ chào đời và thông báo trước tối thiểu 4 tuần cho người sử dụng lao động.Cùng với các chế độ nghỉ thai sản và nghỉ làm cha, các bậc cha mẹ tại Singapore hiện có thể được hưởng tối đa 30 tuần nghỉ phép có lương trong năm đầu đời của trẻ. Bộ trưởng Bộ Phát triển Xã hội và Gia đình Singapore Masagos Zulkifli nhấn mạnh đây là sự điều chỉnh đáng kể, giúp các bậc cha mẹ có thêm thời gian để chăm sóc và gắn kết với trẻ sơ sinh, đồng thời phản ánh nỗ lực sâu rộng của chính phủ Singapore trong thúc đẩy các chính sách hỗ trợ gia đình./.)VOV Thái LanTrẻ nhỏ và các cô bảo mẫu tại trung tâm Babies Inc - Ảnh: Straits Times
VOV1 - Nghị định 46/2026/NĐ-CP - với mục tiêu siết chặt quản lý an toàn thực phẩm- đã vấp phải những vướng mắc trong thực tiễn, nên đã 2 lần được điều chỉnh tạm ngưng hiệu lực. Thực tế này đặt ra những vấn đề gì đối với bài toán quản lý an toàn thực phẩm và năng lực kiến tạo thể chế?Nghị định 46 Quy định chi tiết thi hành một số điều và biện pháp để tổ chức, hướng dẫn thi hành Luật An toàn thực phẩm 2010 và Nghị quyết 66.13 Quy định về công bố, đăng ký sản phẩm thực phẩm có hiệu lực từ ngày 26-1-2026 với nhiều quy định siết chặt quản lý an toàn thực phẩm, đặc biệt đối với thực phẩm nhập khẩu và hoạt động kiểm tra nhà nước về an toàn thực phẩm. Tuy nhiên, do thiếu văn bản hướng dẫn chi tiết về điều kiện chuyển tiếp, việc triển khai đã phát sinh nhiều vướng mắc.Cuối tháng 1-2026, hàng nghìn container hàng hóa bị ùn tắc tại cửa khẩu và cảng biển do không thể hoàn tất thủ tục kiểm tra an toàn thực phẩm theo quy định mới. Các mặt hàng bị ảnh hưởng chủ yếu là nông sản tươi, sản phẩm sơ chế có nguồn gốc thực vật và một số thực phẩm chế biến, đóng gói sẵn.Trước tình hình này, ngày 5-3, Chính phủ đã quyết định tạm dừng thực hiện hai văn bản nêu trên đến ngày 15-4-2026 và áp dụng quy định cũ theo Nghị định 15 trong thời gian chuyển tiếp. Sau khi tiếp tục rà soát và đánh giá tác động, mới đây, Chính phủ quyết định tiếp tục kéo dài thời gian tạm ngưng để tránh xáo trộn chính sách và hoạt động sản xuất, kinh doanh cho đến khi Luật An toàn thực phẩm (sửa đổi) được Quốc hội thông qua và có hiệu lực. Theo kế hoạch, dự án luật sẽ được trình Quốc hội xem xét, thông qua tại kỳ họp thứ 2, quốc hội khóa XVI.Từ câu chuyện cụ thể của việc 2 lần tạm ngưng hiệu lực Nghị định 46 về an toàn thực phẩm, chuyên gia đề xuất giải pháp trọng tâm, ưu tiên về xây dựng chính sách, để vừa đảm bảo an toàn thực phẩm, vừa không cản trở hoạt động sản xuất kinh doanh, và quan trọng hơn là nâng cao năng lực quản trị chính sách của Nhà nước.Từ trái sang phải ảnh: Bà Phạm Thị Ngọc Thủy- Giám đốc điều hành Ban Nghiên cứu Phát triển Kinh tế tư nhân (Ban IV) và BTV Ngọc Diệu
VOV1 - Sáng 19/3, cùng với các địa phương trên cả nước, UBND tỉnh An Giang tổ chức khởi công đồng loạt 03 dự án Trường phổ thông nội trú liên cấp tại các xã biên giới đất liền gồm: Ba Chúc, Vĩnh Xương và Vĩnh Điều, với tổng vốn đầu tư dự kiến hơn 642 tỷ đồng.Bà Phạm Thị Thanh Trà, Bí thư Trung ương Đảng, Phó thủ tướng Chính phủ tham dự lễ khởi công động thổ Trường phổ thông nội trú Tiểu học và THCS Ba Chúc tại xã Ba Chúc. Đây là sự quan tâm của lãnh đạo Đảng, Nhà nước, đã chỉ đạo và tạo điều kiện để các công trình giáo dục tại vùng biên giới sớm được triển khai.Dự án Trường phổ thông nội trú Tiểu học và THCS Ba Chúc được đầu tư cải tạo và xây mới trên tổng diện tích hơn 44 ngàn m². Trong đó diện tích đất mở rộng thêm hơn 24 ngàn m2. Tổng vốn đầu tư dự kiến hơn 189 tỷ 740 triệu đồng, thực hiện đến hết tháng 8/2027.Phó thủ tướng Chính phủ Phạm Thị Thanh Trà và các đại biểu thực hiện nghi thức khởi công, động thổ
CME credits: 0.25 Valid until: 13-03-2027 Claim your CME credit at https://reachmd.com/programs/cme/shifting-the-script-personalizing-overactive-bladder-treatment-in-complex-patients/54125/ This audio-only podcast examines where contemporary approaches fall short when managing overactive bladder (OAB) in patients with complex clinical considerations, including women with persistent symptoms and men with coexisting benign prostatic hyperplasia (BPH). Faculty review clinical considerations supporting earlier use of β₃-adrenergic agonists within team-based care pathways. Through case-based scenarios, the program highlights practical strategies for patient selection, reassessment, and treatment escalation in both men and women, including men receiving pharmacologic therapy for BPH who continue to experience storage symptoms. =
Sylvester ist im Urlaub, daher springt kurzerhand Jan Mahn von der c't ein. Und der hat eine brisante Geschichte mitgebracht, in der es um "Bulletproof Hoster" geht. Also um Anbieter, die auf die guten Sitten im Internet pfeifen - manchmal gar auf Recht und Gesetz - solange ihre oft zwielichtige Kundschaft ihnen monatlich Geld überweist. Doch vorher gibt es einen längeren Rant über einen Security-Appliance-Hersteller, den Christopher sich nicht selber ausgedacht hat, sondern den der Finanz-Nachrichtendienst Bloomberg veröffentlichte. Und es gibt einige PKI-Neuigkeiten, die fast alle etwas mit IP-Adressen zu tun haben.
February 27, 2026 In this episode, Scott, Mark, and special guest Dr. John Lin tackle real-world evaluation and management (E/M) scenarios submitted by members of the Thriving Urology Practice Facebook Group. Through practical examples—including BPH follow-ups, elevated PSA management, overactive bladder, recurrent UTIs, and constipation—they break down how to apply medical decision-making rules to determine the correct level of service. The discussion highlights chronic stable conditions, prescription drug management, documentation pitfalls, automatic downcoding, and the ongoing gray areas that make E/M leveling “clear as mud.” The key takeaway: understanding the rules is essential—but precise documentation is what ultimately gets you paid. PRS Coding and Reimbursement HubAccess the HubFree In-Office Prostate Biopsy Calculator (Suppoted by UC-Care)Download NowPRS Coding CoursesFor UrologistFor APPsFor Coders, Billers, and Admins Join the Urology Pharma and Tech Pioneer GroupEmpowering urology practices to adopt new technology faster by providing clear reimbursement strategies—ensuring the practice gets paid and patients benefit sooner. https://www.prsnetwork.com/joinuptpClick Here to Start Your Free Trial of AUACodingToday.com The Thriving Urology Practice Facebook group.The Thriving Urology Practice Facebook Group link to join:https://www.facebook.com/groups/ThrivingPractice/
Most men are told prostate issues are “just part of aging.”But the real problem nobody's talking about isn't just symptoms—it's what's happening underneath them.In this episode, Dr. Lizabeth Roy (board-certified functional & integrative medicine physician) breaks down:• Why enlarged prostate (BPH) is often treated like “normal” when it may not be• The hidden chronic inflammation + infection pattern many men never get tested for• The surprising gut → prostate connection (and why it matters for prevention)• Why prostate cancer often has no symptoms and what proactive men can do earlier• How immune system exhaustion can quietly set the stage for bigger problemsIf you're dealing with frequent urination, urgency, incomplete emptying, pain, or just want to stay ahead of your health—this is a must-watch.✅ Subscribe for expert conversations that help you make smarter decisions as a high performer
Prostate artery embolization may be performed by interventional radiologists, but its indications are rooted in urologic evaluation. In the second installment of our 2026 PAE University Series, Dr. Chris Beck is joined by Dr. Art Rastinehad of Northwell Health, a urologist with formal interventional radiology training, to share how his dual background informs both when to offer PAE and how to execute it thoughtfully. --- This podcast is supported by an educational grant from Guerbert. --- SYNPOSIS Dr. Rastinehad discusses his path from urology into IR and how that combined training shapes his current hybrid practice. He outlines a practical BPH consult framework grounded in urologic evaluation, emphasizing appropriate imaging, careful patient selection, and the importance of ruling out malignancy before proceeding with embolization. From his perspective, durable outcomes begin with disciplined workup and clear counseling around expectations, including sexual side effects and alternative treatment options. The conversation then turns to procedural strategy. Dr. Rastinehad reviews anatomic considerations, large-gland and technically challenging cases, and his experience incorporating liquid embolics into PAE. He compares glue and particles, detailing workflow decisions, medication strategy, and post-procedure management. Throughout, he highlights scenarios where PAE may not be the most appropriate intervention and how other BPH tools may better serve the patient. The episode concludes with a discussion of the future of PAE, including questions of training, collaboration between specialties, and reimbursement; underscoring the value of cross-specialty insight in contemporary BPH care. --- TIMESTAMPS 00:00 - Introduction01:26 - Interventional Urologist with IR Roots04:13 - Leaving Urology for IR: Fellowship Life, Case Volume & Mentors08:45 - Building a Hybrid Urology/IR Practice14:32 - PAE Benefits, Sexual Side Effects & Why MRI Matters17:39 - BPH Consult Playbook22:17 - Anatomy Deep Dive24:27 - Edge Cases & Big Glands28:24 - Why Glue?35:39 - Glue vs Particles39:40 - Post-PAE Follow-Up41:28 - Antibiotics and Medications46:18 - Tough Cases50:53 - The Future of PAE --- RESOURCES Early Outcomes of Prostatic Artery Embolization using n-Butyl Cyanoacrylate Liquid Embolic Agent: A Safety and Feasibility Studyhttps://pubmed.ncbi.nlm.nih.gov/39074551/ Dr. Rastinehad's Websitehttps://drrastinehad.com/
Highlights from the ANH conference in PhoenixWhat do you think of the supplements I'm taking for borderline osteoporosis?After years of vegetarianism, wouldn't eating meat cause adverse reactions like headaches or nausea?
This episode explores tadalafil (Cialis) as a potential longevity drug, though no randomized human trials prove it extends lifespan. Cialis works by blocking PDE5, enhancing nitric oxide signaling, and improving blood flow through vasodilation. Originally approved for pulmonary hypertension, it's also used for erectile dysfunction and BPH. Its 36-hour half-life makes it superior to Viagra for continuous longevity effects. The host frames vascular aging and endothelial dysfunction as key drivers of age-related diseases (heart disease, stroke, dementia, kidney disease). Observational data shows Cialis users have 44% lower mortality, fewer cardiovascular events, reduced dementia risk, and lower mortality in diabetics. Additional benefits include improved cardiac function, reduced infarct size, arrhythmia suppression, and regression of left ventricular hypertrophy. A 2024 meta-analysis found it lowers hemoglobin A1C, possibly via improved microvascular perfusion, insulin sensitivity, and mitochondrial function. Cialis crosses the blood-brain barrier and may improve neurovascular coupling and hippocampal plasticity, potentially benefiting those with or at risk of dementia. Safety is generally good with long-term daily use (2.5–5 mg), though cautions include avoiding use with nitrates, low blood pressure, or certain retinal disorders. Common side effects are headache, nasal congestion, and acid reflux. The host recommends consulting a doctor and references potential synergy with telmisartan. Tadalafil (Cialis) — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a604008.html](https://medlineplus.gov/druginfo/meds/a604008.html) Sildenafil (Viagra) — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a699015.html](https://medlineplus.gov/druginfo/meds/a699015.html) Key mechanisms mentioned Nitric Oxide (NO) — NCBI Bookshelf: [https://www.ncbi.nlm.nih.gov/books/NBK554485/](https://www.ncbi.nlm.nih.gov/books/NBK554485/) Cyclic GMP (cGMP) — NCBI Bookshelf: [https://www.ncbi.nlm.nih.gov/books/NBK542234/](https://www.ncbi.nlm.nih.gov/books/NBK542234/) Conditions mentioned in the episode Benign Prostatic Hyperplasia (BPH) — MedlinePlus: [https://medlineplus.gov/benignprostatichyperplasia.html](https://medlineplus.gov/benignprostatichyperplasia.html) Pulmonary Arterial Hypertension (PAH) — MedlinePlus: [https://medlineplus.gov/pulmonaryhypertension.html](https://medlineplus.gov/pulmonaryhypertension.html) Blood pressure drug mentioned Telmisartan — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a601249.html](https://medlineplus.gov/druginfo/meds/a601249.html) Other longevity / comparison drugs mentioned Metformin — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a696005.html](https://medlineplus.gov/druginfo/meds/a696005.html) Sirolimus (Rapamycin) — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a602026.html](https://medlineplus.gov/druginfo/meds/a602026.html) Side-effect helper mentioned Ibuprofen (Advil) — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a682159.html](https://medlineplus.gov/druginfo/meds/a682159.html) Dementia meds mentioned Donepezil (Aricept) — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a697032.html](https://medlineplus.gov/druginfo/meds/a697032.html) Amantadine — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a682064.html](https://medlineplus.gov/druginfo/meds/a682064.html) Lab markers mentioned Hemoglobin A1C (HbA1c) test — MedlinePlus lab test: [https://medlineplus.gov/lab-tests/hemoglobin-a1c-hba1c-test/](https://medlineplus.gov/lab-tests/hemoglobin-a1c-hba1c-test/) Insulin in blood test — MedlinePlus lab test: [https://medlineplus.gov/lab-tests/insulin-in-blood/](https://medlineplus.gov/lab-tests/insulin-in-blood/) People referenced (where the claims were mentioned) Huberman Lab (Dr. Andrew Huberman) — site: [https://www.hubermanlab.com/](https://www.hubermanlab.com/) Clip about low-dose tadalafil (2.5–5mg) — X post: [https://x.com/tbpn/status/2022350426394534334](https://x.com/tbpn/status/2022350426394534334) Bryan Johnson (Blueprint) — site: [https://blueprint.bryanjohnson.com/](https://blueprint.bryanjohnson.com/) Dr. David Sinclair (Harvard profile) — site: [https://sinclair.hms.harvard.edu/people/david-sinclair](https://sinclair.hms.harvard.edu/people/david-sinclair) Show Notes 00:00 Welcome to the Hart2Heart Podcast. 01:56 What Cialis Is: PDE5 Inhibition, cGMP & Nitric Oxide Explained 03:43 Approved Uses & Origin Story: Pulmonary Hypertension, ED, and BPH 05:33 Why Cialis Over Viagra: 36-Hour Half-Life & 24/7 Vascular Benefits 06:52 Vascular Aging 101: Endothelium, Perfusion, and Why It Drives Disease 11:14 What the Human Data Shows: Observational Evidence for Mortality, CVD & Dementia 13:04 Mechanisms Deep Dive: Heart Protection, Heart Failure, and Anti-Atherosclerosis 15:02 Cialis for Diabetics: Lowering A1C and Improving Insulin Sensitivity 16:21 Brain Effects: Blood–Brain Barrier, Neurovascular Coupling & Dementia Potential 18:21 Safety, Who Should Avoid It, and Daily Longevity Dosing (2.5–5 mg) + Wrap-Up The Hart2Heart podcast is hosted by family physician Dr. Michael Hart, who is dedicated to cutting through the noise and uncovering the most effective strategies for optimizing health, longevity, and peak performance. This podcast dives deep into evidence-based approaches to hormone balance, peptides, sleep optimization, nutrition, psychedelics, supplements, exercise protocols, leveraging sunlight, and de-prescribing pharmaceuticals — using medications only when absolutely necessary. Beyond health science, we explore the intersection of public health and politics, exposing how policy decisions shape our health landscape and what actionable steps people can take to reclaim control over their well-being. Guests range from out-of-the-box thinking physicians such as Dr. Casey Means (author of "Good Energy") and Dr. Roger Sehult (Medcram lectures) to public health experts such as Dr. Jay Bhattacharya (Director of the National Institutes of Health (NIH) and Dr. Marty Mckary (Commissioner of the Food and Drug Administration (FDA) and high-profile names such as Zuby and Mark Sisson (Primal Blueprint and Primal Kitchen). If you're ready to take control of your health and performance, this podcast is for you.We cut through the jargon and deliver practical, no-BS advice that you can implement in your daily life, empowering you to make positive changes for your well-being. Connect with Dr. Mike Hart Instagram: @drmikehart Twitter: @drmikehart Facebook: @drmikehart
Is it your bladder… or your prostate?
In this powerful Q&A episode of The Armor Men's Health Show, Donna Lee sits down with board-certified urologist and Urology Specialists of Austin's very own Dr. Lucas Jacomides to tackle two deeply personal listener questions that many men are quietly struggling with.First, a 65-year-old listener asks a question that cuts to the core of men's health advocacy: Why do we wait for prostate cancer before taking action? With a long history of severe BPH, multiple TURP procedures, bladder incontinence, and a strong family history of cancer, he wants to know how to find a provider who treats the whole person—not just a diagnosis. Dr. Jacomides breaks down the medical reasoning, explores proactive options, and explains how patients can advocate for care that aligns with their quality-of-life goals.Next, the conversation turns to Peyronie's Disease—what it is, how it affects men physically and emotionally, and the real-world treatment options available today. Dr. Jacomides offers a clear, compassionate explanation of how he approaches this condition with patients and what expectations should look like moving forward.This episode is packed with insight, education, and reassurance for men who want answers—and for partners who want to better understand the challenges men face. If you're looking for honest conversations and expert guidance on men's health, this is one you won't want to miss.
As men and their loved ones explore treatment options for prostate cancer, it's encouraging to know that ongoing innovation is shaping the management of this condition as technology advances. Today, we have the privilege of speaking with Dr. Mark Hong, a pioneer of an advanced treatment for men with prostate cancer and/or BPH, known as Transurethral Ultrasound Ablation, or TULSA. It is a minimally invasive MRI-guided procedure that destroys cancerous tissue while minimizing side effects. We're thrilled to partner with Profound Medical to introduce today's special guest. Dr. Hong is a board-certified urologist at Integrative Urology in Phoenix, Arizona, and a pioneer of MRI-guided TULSA-PRO incision-free surgery for prostate cancer. He completed his urology residency at Harvard Medical Center and earned selection as a national CAPTURE Scholar in prostate cancer. That allowed him to lead projects alongside world-leading scientists from the Dana-Farber Cancer Institute and the University of California, San Francisco. He also completed a fellowship in robotic and minimally invasive surgery at George Washington University in Washington, DC. He has published in almost every major international urology journal, having authored publications on topics ranging from prostate cancer detection to healthcare policy. Dr. Hong joins us today to share more about TULSA-PRO for men with prostate cancer. Having completed over 200 procedures, he has performed more TULSA procedures as an independent urologist, in the absence of a radiologist, than any other urologist in the world. Stay tuned for more! Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation. Show Highlights: Dr. Hong clarifies what the TULSA procedure is How the TULSA procedure differs from other technologies, in terms of its delivery, advantages, and outcomes Who are the ideal candidates for the TULSA procedure? The potential risks associated with the TULSA procedure What patients undergoing the TULSA procedure can expect How the development of new technologies leads to better outcomes for men with prostate cance Links: Follow Dr. Pohlman on Twitter and Instagram - @gpohlmanmd. Get your free What To Expect Guide (or find the link on our podcast website) Join our Facebook group Follow Dr. Pohlman on Twitter and Instagram Sign up for the Prostate Health Academy You can access Dr. Pohlman's free mini-webinar, where he discusses his top three tips to promote men's prostate health, longevity, and quality of life here. Podcast Partner: Profound Medical TULSA-PRO: https://tulsaprocedure.com/
Join My Private Group: https://theaxioncollective.manus.space/Email List: https://huntershealthhacks.beehiiv.com/Get My Book On Amazon: https://a.co/d/avbaV48DownloadThe Peptide Cheat Sheet: https://peptidecheatsheet.carrd.co/Download The Bioregulator Cheat Sheet: https://bioregulatorcheatsheet.carrd.co/1 On 1 Coaching Application: https://hunterwilliamscoaching.carrd.co/Book A Call With Me: https://hunterwilliamscall.carrd.co/Supplement Sources: https://hunterwilliamssupplements.carrd.co/Amazon Storefront: https://www.amazon.com/shop/hunterwilliams/list/WE16G2223BXA?ref_=cm_sw_r_cp_ud_aipsflist_R7QWQC0P1RACB2ETY3DYSocials:Instagram: https://www.instagram.com/hunterwilliamscoaching/Video Topic Request: https://hunterwilliamsvideotopic.carrd.co/In today's episode, I'm breaking down a peptide that doesn't get nearly enough attention, but can be genuinely life-changing for the right person: Vesilute.This is one of the Russian peptide bioregulators developed at the St. Petersburg Institute of Bioregulation and Gerontology, and in this episode I'm specifically focusing on the injectable bladder peptide, not the oral version. If you've heard me talk about Prostamax before, Vesilute is its natural counterpart on the bladder side — and when paired together, they form what I call a bladder–prostate axis strategy for comprehensive urinary health in men. For women, Vesilute stands on its own as a powerful option for overactive bladder, especially during peri- and post-menopause.I walk through exactly how Vesilute works at a cellular level — how these tissue-specific peptides enter bladder cells, influence gene expression, and help restore a more youthful, functional state to the urothelium and detrusor muscle. We talk about why urgency, frequency, weak flow, nocturia, and even that awkward “can't go when you need to” situation happen as we age, and how Vesilute may help normalize those patterns rather than just masking symptoms.I also dig into the Russian clinical data, including placebo-controlled trials in men with BPH and women with overactive bladder, showing meaningful improvements in urinary flow, symptom scores, and quality of life — all with an excellent safety profile and virtually no systemic side effects. This is where AI translation has really opened the door to research that's been siloed for years, and I share what I found most compelling.From there, I outline my preferred injectable protocol: 1–2 mg daily for 60 days, run 2–3 times per year, why I prefer that over shorter high-dose protocols, and how to pair Vesilute with Prostamax in men for better overall results. I also talk through what people typically notice week by week, how long benefits tend to last after a cycle, and why even reducing nighttime urination from three trips to one can have massive downstream effects on sleep, energy, mood, metabolism, and overall longevity.This isn't a hype peptide. It's not flashy. But if bladder issues, frequent urination, BPH, or overactive bladder are impacting your sleep or quality of life, this may be one of the most underrated and cost-effective peptides you can use. My goal with this episode is to give you the full context — the science, the data, the real-world experience — so you can decide if it makes sense for you.As always, thank you for the support, for being here, and for helping me keep this information free and accessible. If you've used Vesilute, I'd love for you to share your experience in the comments so others can learn from it too.
In this episode, Dr. Rena Malik, MD welcomes Dr. Aaron Fischman to discuss prostate artery embolization (PAE) as a minimally invasive treatment for benign prostatic hyperplasia (BPH). Together, they explore the short-term and long-term outcomes, potential complications, recovery expectations, and the evolving techniques that aim to improve patient results. The conversation provides listeners with practical insights into candidate selection, procedural advancements, and why expertise and patient preparation are key for successful outcomes in PAE. Become a Member to Receive Exclusive Content: renamalik.supercast.com Schedule an appointment with me: https://www.renamalikmd.com/appointments ▶️Chapters: 00:00 Post-embolization symptoms 01:11 Downtime and activity limits 02:25 Readmission and symptom management 03:11 Long-term success and recurrence 06:29 Expected side effects 08:15 Radiation exposure risks 09:45 Ideal candidates for embolization Stay connected with Dr. Aaron Fischman on social media for daily insights and updates. Don't miss out—follow him now and check out these links! X - https://x.com/bonesz?s=21&t=capJF_nC6iMJjJWqHuZeYw LINKEDIN - https://www.linkedin.com/in/aaron-fischman-md-fsir-fcirse-fsvm-213a234?utm_source=share&utm_campaign=share_via&utm_content=profile&utm_medium=ios_app YOUTUBE - https://youtube.com/@aaronfischmanmd?si=wP7jb0Za32H9Y_mE Let's Connect!: WEBSITE: http://www.renamalikmd.com YOUTUBE: https://www.youtube.com/@RenaMalikMD INSTAGRAM: http://www.instagram.com/RenaMalikMD TWITTER: http://twitter.com/RenaMalikMD FACEBOOK: https://www.facebook.com/RenaMalikMD/ LINKEDIN: https://www.linkedin.com/in/renadmalik PINTEREST: https://www.pinterest.com/renamalikmd/ TIKTOK: https://www.tiktok.com/RenaMalikMD ------------------------------------------------------ DISCLAIMER: This podcast is purely educational and does not constitute medical advice. The content of this podcast is my personal opinion, and not that of my employer(s). Use of this information is at your own risk. Rena Malik, M.D. will not assume any liability for any direct or indirect losses or damages that may result from the use of information contained in this podcast including but not limited to economic loss, injury, illness or death. Learn more about your ad choices. Visit megaphone.fm/adchoices
If you're a man in your 50s, 60s, or 70s waking up at night to pee, planning your day around bathroom access, or quietly worrying about erections and testosterone, this episode is for you. Dr. Geo sits down with Dr. Ravi Munver (Hackensack University Medical Center) to break down what's actually driving urinary symptoms, how to tell “prostate vs bladder,” when waiting too long can permanently weaken your bladder, and how today's BPH procedures compare—especially Aquablation (high-pressure, room-temperature waterjet therapy).What you'll learn in this episode• Why BPH symptoms can start earlier than most men think (and why more men are finally talking about it)• Why prostate size does NOT equal symptom severity (big prostate ≠ big problem… always)• How to distinguish “prostate obstruction” vs overactive bladder—and why you can't reliably do this without proper testing• The “danger zone”: when untreated obstruction can lead to a weakened/crippled bladder• Medication options: what each class does, who it's for, and the most common side effects• The full “toolbox” of procedures—from office-based options to the most durable surgical solutions• Why Aquablation is changing the conversation (symptom relief + low sexual side effects + broad size range)Episode chapters (timestamps)00:00:00 00:02:00 Why younger men are showing up with urinary symptoms Prostate growth patterns (growth early, pause, then growth again in the 40s); increased awareness, openness, and access to information.00:07:00 “Blame the organ you have” — prostate vs overactive bladder Why symptoms overlap; why only a clinician can truly differentiate causes.00:10:00 When should a man see a urologist? When symptoms interfere with life (work, travel, sleep). The real issue is often difficulty returning to sleep.00:13:00 The risk of waiting: bladder decompensation How long-term obstruction can lead to a weakened bladder and urinary retention.00:18:00 The holistic patient scenario + why objective testing matters Why symptoms can “seem better” while retention worsens; importance of measuring PVR and other tests.00:21:00 Medications for BPH—pros/cons• Alpha blockers: tamsulosin (Flomax), alfuzosin, silodosin (Rapaflo)• 5-alpha reductase inhibitors: finasteride, dutasteride• Tadalafil (Cialis) daily 5 mg: dual benefits for BPH + erectile function00:31:00 The modern BPH procedure toolbox TURP as the historical “gold standard,” plus lasers, robotic options, office-based procedures, and newer technologies.00:36:00 What men care about most when choosing a procedure Incontinence risk, erectile dysfunction risk, ejaculatory changes, irritative symptoms, and durability/retreatment rates.00:38:00 Robotic Simple Prostatectomy — what “simple” actually means Removing the obstructing inner tissue while leaving the capsule; major symptom relief for large prostates, with tradeoffs (especially ejaculation).00:43:00Aquablation explained (high-pressure water therapy) Image-guided treatment planning + robotic waterjet tissue removal with minimal thermal damage.00:48:00 Durability and size range Discussion of longer-term data vs TURP and why Aquablation can treat very large prostates.00:51:00 If Aquablation isn't available—what's next best? How options shift based on prostate size and the priority to preserve ejaculation vs maximize durability.00:54:00 Final guidance + where to find Dr. Munver Individualized care; find a urologist who can offer a broad set of options.___________________________________
Please visit answersincme.com/FUA860 to participate, download slides and supporting materials, complete the post test, and get a certificate. In this activity, an expert in urology discusses overactive bladder in men with benign prostatic hyperplasia. Upon completion of this activity, participants should be better able to: Identify overactive bladder (OAB) in men who are being treated for benign prostatic hyperplasia (BPH); Review pharmacotherapy treatment expectations for treating OAB in men with BPH; and Formulate strategies to enhance treatment plans and support quality of life for men with OAB and BPH, including those with additional comorbidities.
Medsider Radio: Learn from Medical Device and Medtech Thought Leaders
In this episode of Medsider Radio, we sat down Dr. Adam Kadlec, practicing urologist and co-founder of Rivermark Medical.Rivermark is a clinical-stage company developing FloStent, a first-line, reversible device therapy for benign prostatic hyperplasia (BPH).Before launching Rivermark, Adam built a thriving urological practice in Milwaukee and consulted for several device companies — experiences that ultimately revealed how early true device development begins and why physicians rarely get the chance to influence innovation upstream. Partnering with medtech operator Andy Doraiswamy, Adam transitioned from clinician to CEO and is now leading Rivermark through its pivotal trial.In this interview, Adam shares why workflow integration is one of the most overlooked drivers of adoption, how physician-innovators can build the right decision-making infrastructure, and why understanding who actually enrolls patients at clinical sites can make or break a trial. He also touches on the mindset required to stay resilient through the ups and downs of building a medtech startup.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Adam Kadlec.
The post 146 Penile disorders, BPH and a key to focus appeared first on Physician Assistant Exam Review.
====================================================SUSCRIBETEhttps://www.youtube.com/channel/UCNpffyr-7_zP1x1lS89ByaQ?sub_confirmation=1==================================================== DEVOCIÓN MATUTINA PARA JÓVENES 2025“HOY ES TENDENCIA”Narrado por: Daniel RamosDesde: Connecticut, USAUna cortesía de DR'Ministries y Canaan Seventh-Day Adventist Church===================|| www.drministries.org ||===================15 de NoviembreLos beneficios de dar«Teniendo presente aquella máxima de Jesús, el Señor:"Más dicha trae el dar que el recibir"». Hechos 20: 35, BPHEn 1776, el teólogo alemán J. G. Körner acuñó una nueva palabra para referirse a las declaraciones atribuidas a Jesús que no se encuentran en los cuatro Evangelios. Dicha palabra fue agrapha. El mejor ejemplo de una agrapha es justo el versículo de hoy. Pablo señala que Jesús dijo que: «Más dicha trae el dar que el recibir». Los cristianos a menudo citamos esta declaración para motivar a la generosidad, pero ¿de verdad me trae más dicha dar que recibir? A simple vista la respuesta es «no». Después de todo, ¿a quién no le gusta recibir regalos? Sin embargo, las investigaciones en el campo de la psicología le dan la razón al Maestro.Un estudio realizado por Jordan Grafman reveló que los centros de placer del cerebro muestran el mismo nivel de actividad cuando vemos a alguien donar dinero que cuando recibimos dinero nosotros mismos. De hecho, «dar dinero a otros aumenta la sensación de bienestar mucho más que cuando gastamos el dinero en nosotros mismos».* Elizabeth Dunn, de la Universidad de British Columbia, realizó un experimento en el que los participantes recibieron una suma de dinero. A la mitad se le dijo que gastara el dinero en ellos mismos; mientras que a la otra mitad se le dijo que gastara el dinero en otros. Al final del estudio, los participantes que gastaron el dinero en otros se sentían mucho más felices que los que usaron el dinero para su beneficio propio. Otros estudios revelan que dar aumenta la felicidad independientemente de la edad, el país de procedencia o la situación económica del que da.Sentimos placer y felicidad al dar porque fuimos creados a imagen y semejanza de Dios (ver Génesis 1: 26), por eso que tenemos el potencial de ser tan generosos como Aquel que «abre generosamente su mano y sacia a todo ser viviente» (ver Salmos 145: 16, BPH). No importa cuánto dinero tengamos, sino lo que hagamos con él. Como bien dijo Russell James: «Al final, la ciencia del cerebro parece mostrarnos que dar dinero para beneficiar a otros es, después de todo, una cuestión de corazón».
I have hypothyroidism. Do I need to be concerned about low ferritin levels?What are the benefits of lower-dose fish oil?Is there a connection between melatonin supplementation and depression?Can I take melatonin while on warfarin?What to do about the state of our healthcare system?
Are children's IQs going down?An overview of medical reversalsCan you comment on the melatonin and heart failure study?Result of a prostate artery embolization
Dr. Geo and Dr. Robert Caruso dive deep into what really causes urinary symptoms in men—and why prostate size alone doesn't tell the full story. Dr. Caruso shares how his “blue zone” Italian upbringing, his 98-year-old mother, and even a family story involving a bear shaped his holistic view of urology, where diet, movement, spine health, constipation, and sleep apnea all matter. From there, they walk through medications (alpha-blockers, 5-alpha-reductase inhibitors, daily tadalafil) and when each actually makes sense, including surprising cardiovascular and nocturia benefits of PDE5 inhibitors. The conversation then shifts to procedures: bipolar TURP vs classic TURP, and in-office options like UroLift, Rezūm steam therapy, and the newer iTind device—who they're for, how they're done, and what to expect for recovery, ejaculation, and long-term results. By the end, you'll know what questions to bring to your urologist, how to think beyond “just the prostate,” and when vapor therapy or other minimally invasive treatments may be the right next step for your BPH.Time-Stamped Highlights00:00 – Why surgery isn't the only answer for BPH-Dr. Geo introduces Dr. Caruso and frames the episode around minimally invasive, real-world solutions for urinary symptoms.05:00 – Blue-zone lifestyle, Italian roots, and holistic urology-Dr. Caruso's upbringing, his 98-year-old mother, and how growing food, movement, and nature shape his approach to men's health.15:00 – It's not “just the prostate”: spine, sleep, and metabolism-How back and neck issues, constipation, diabetes, and sleep apnea can drive frequency and nocturia just as much as gland size.25:00 – Meds that do more: tadalafil, alpha-blockers, and 5-ARIs-When daily tadalafil can help erections, BPH, and nocturia; who might benefit from alpha-blockers or finasteride/dutasteride—and who probably shouldn't.35:00 – From TURP to in-office options: choosing the right procedure-Bipolar TURP for large prostates and median lobes vs. office-based UroLift, Rezūm steam therapy, and iTind—what they are, how long they last, and what to ask your urologist about ejaculation, catheters, and recovery.________________________
Hi there, amazing listeners of The Armor Men's Health Show! Welcome back to another enlightening and entertaining episode. Donna Lee is joined today by board certified urologist Dr. Lucas Jacomides as they dive into more of your thoughtful listener questions. Donna Lee and Dr. Jacomides are both employed by Urology Specialists of Austin, the parent company of Armor Men's Health and The Armor Men's Health Show Podcast. In this episode, they tackle:• A post-TURP/TUIP concern: A 72-year-old listener asks why his ejaculatory response has diminished after surgery—going from “three strong pumps” to “one weak pump”—and whether there's any way to improve it.• An ED challenge: Another listener wonders if all erectile dysfunction can be improved, even when dealing only with BPH and high blood pressure, especially after pills, shockwave therapy, and injections haven't done the trick.Tune in as Dr. Jacomides breaks down the “why,” the “what now,” and the most effective next steps for both of these important men's health questions.Remember to send your questions in for anonymous answers by a board certified Urologist or urology Provider at Urology Specialists of Austin! Visit www.armormenshealth.com to submit your questions. Stay healthy out there! Voted top Men's Health Podcast, Sex Therapy Podcast, and Prostate Cancer Podcast by FeedSpot.Dr. Mistry is a board-certified urologist and has been treating patients in the Austin and Greater Williamson County area since he started his private practice, NAU Urology Specialists (now Urology Specialists of Austin), in 2007. Donna Lee works with Dr. Mistry as Urology Specialists of Austin's Director of Business Development and she's also a professional standup comedian touring the country. We enjoy hearing from you! Visit www.armormenshealth.com to submit a question and we'll answer your questions anonymously in an upcoming episode! Phone: (512) 238-0762Website: www.armormenshealth.comEmail: armormenshealth@gmail.comOur Locations:Round Rock Office970 Hester's Crossing Road Suite 101 Round Rock, TX 78681South Austin Office6501 South Congress Suite 1-103 Austin, TX 78745Lakeline Office12505 Hymeadow Drive Suite 2C Austin, TX 78750Dripping Springs Office170 Benney Lane Suite 202 Dripping Springs, TX 78620
In this episode, we dive into Benign Prostatic Hyperplasia (BPH) — a common but often misunderstood condition affecting many veterans — and how it can qualify for VA disability compensation.BPH, also known as enlarged prostate, can cause significant urinary symptoms and affect daily life. While it's common in aging men, veterans may experience it earlier or more severely due to service-related exposures, stress, or secondary conditions. We'll explore how to establish service connection, what VA rating criteria apply, and how to build a strong claim or appeal.
As little as 3000 steps per day can slow progression to Alzheimer's Disease; Self-reports of memory impairment soaring among young people; New study vindicates unprocessed red meat—and even often-vilified processed red meat—for cancer and overall health. Prostate artery embolization (PAE) offers new non-invasive option for men's age-related urinary problems; Targeting the mitochondria and the microbiome for Parkinson's Disease; Popular prostate and hair loss prevention drugs linked to depression and suicide—while Cialis for urinary symptoms may stave off cardiovascular disease; Discovery that a safe, cheap medication may increase survival after breast cancer surgery.
SUMMARY In this episode of "Vibe Science," host Ryan Alford interviews Scott Hickle, CEO of Throne, about their smart toilet device that uses AI and computer vision to monitor gut health, urinary function, and hydration. Scott explains how the device analyzes bowel movements and urine flow to provide early warnings for conditions like IBS, IBD, BPH, dehydration, and colon cancer. They discuss the device’s development, privacy concerns, and its potential to revolutionize preventive healthcare. The episode highlights Throne’s role in empowering users with actionable health insights and contributing valuable data to medical research. TAKEAWAYS Importance of gut health and early detection of health issues. Overview of Throne's smart toilet device and its functionality. Analysis of bowel movements and urinary patterns using AI and computer vision. Health conditions addressed by the device, including IBS, IBD, BPH, and colon cancer. Challenges with current colon cancer screening methods and Throne's innovative approach. User privacy concerns and initial skepticism about the device. Technical aspects of the device, including data collection and analysis methods. Future developments and features planned for the Throne device. Collaboration with research institutions to analyze health data for medical advancements. The potential impact of continuous health monitoring on preventive healthcare. This episode is sponsored by: Warrior Salt Electrolyte Powder – Hydrate & Reenergize Naturally Experience Warrior Salt's all-natural electrolyte powder for optimal hydration and performance. Boost energy, prevent cramps, and stay hydrated. Order Now!
In this conversation, Dr. Dean Elterman, Associate Professor of Urology at the University of Toronto and a sub-specialist in functional urology, discusses benign prostatic hyperplasia (BPH), a common condition affecting men as they age. He explains the causes, symptoms, and various treatment options available, including medications, traditional surgeries, and minimally invasive procedures. The discussion also touches on the role of AI in improving treatment outcomes and the importance of lifestyle changes in managing BPH. Dr. Elterman emphasizes the need for awareness and proactive management of urinary symptoms.#prostatehealth
In this episode, Dr. Rena Malik, MD sits down with Dr. Aaron Fischman to explore the latest advances in prostate artery embolization for treating BPH and urinary symptoms. They discuss the types of materials used, procedural innovations, patient evaluation, and success rates, while emphasizing the importance of proper assessment and minimizing sexual side effects. Listeners will gain practical insights into how this minimally invasive procedure can improve quality of life for men with enlarged prostates. Become a Member to Receive Exclusive Content: renamalik.supercast.com Schedule an appointment with me: https://www.renamalikmd.com/appointments Stay connected with Dr. Aaron Fischman on social media for daily insights and updates. Don't miss out—follow him now and check out these links! X - https://x.com/bonesz?s=21&t=capJF_nC6iMJjJWqHuZeYw LINKEDIN - https://www.linkedin.com/in/aaron-fischman-md-fsir-fcirse-fsvm-213a234?utm_source=share&utm_campaign=share_via&utm_content=profile&utm_medium=ios_app YOUTUBE - https://youtube.com/@aaronfischmanmd?si=wP7jb0Za32H9Y_mE ▶️Chapters: 00:00 Embolization materials used00:31 Particle vs. glue embolization01:50 Technical advances in procedure03:12 Radiation exposure discussion04:37 Patient evaluation process07:39 Success rates and candidacy10:28 Treating urinary retention12:10 Risks and side effects16:11 Symptom relief timeline Let's Connect!: WEBSITE: http://www.renamalikmd.com YOUTUBE: https://www.youtube.com/@RenaMalikMD INSTAGRAM: http://www.instagram.com/RenaMalikMD TWITTER: http://twitter.com/RenaMalikMD FACEBOOK: https://www.facebook.com/RenaMalikMD/ LINKEDIN: https://www.linkedin.com/in/renadmalik PINTEREST: https://www.pinterest.com/renamalikmd/ TIKTOK: https://www.tiktok.com/RenaMalikMD ------------------------------------------------------ DISCLAIMER: This podcast is purely educational and does not constitute medical advice. The content of this podcast is my personal opinion, and not that of my employer(s). Use of this information is at your own risk. Rena Malik, M.D. will not assume any liability for any direct or indirect losses or damages that may result from the use of information contained in this podcast including but not limited to economic loss, injury, illness or death. Learn more about your ad choices. Visit megaphone.fm/adchoices
Dr. Hoffman continues his conversation with Dr. Geo Espinosa, one of America's foremost integrative urologists.
Dr. Geo Espinosa, one of America's foremost integrative urologists, dishes on men's urinary problems, natural support for testosterone, and prostate cancer. Lifestyle factors—diet, exercise, sleep and stress reduction—play an important role in all phases of urological health. Dr. Geo explains how he interacts with conventional urologists on the faculty of NYU Langone Medical Center where he practices. Why are men's urinary problems not just a matter of prostate size? How can natural strategies alleviate urinary difficulties without the need for surgery or drugs? Besides saw palmetto, what nutraceuticals can benefit men with urinary problems? Are there really natural herbal alternatives to testosterone? For men with prostate cancer who are under active surveillance, is there anything more that can be done to minimize their chance of eventually needing surgery or radiation? What nutraceuticals, vitamins and minerals have anti-prostate cancer potential?